May 10 |
Verona Pharma PLC Reports Q1 2024 Earnings: A Detailed Financial and Strategic Overview
|
May 10 |
Verona Pharma plc (NASDAQ:VRNA) Q1 2024 Earnings Call Transcript
|
May 9 |
Verona Pharma gets $650M in financing ahead of June FDA decision on COPD asset
|
May 9 |
Verona Pharma plc (VRNA) Q1 2024 Earnings Call Transcript
|
May 9 |
Verona Pharma GAAP EPS of -$0.04 beats by $0.09
|
May 9 |
Verona Pharma Reports First Quarter 2024 Financial Results and Provides Corporate Update
|
May 9 |
Verona Pharma Announces $650 Million Strategic Financing with Oaktree and OMERS
|
May 8 |
Verona Pharma Q1 2024 Earnings Preview
|
May 2 |
Verona Pharma to Present Additional Analyses of Positive Phase 3 ENHANCE Studies in COPD at ATS 2024
|
Apr 25 |
Verona Pharma to Report First Quarter 2024 Financial Results and Provide Corporate Update
|